a better understanding of the use of chemotherapy and the success in achieving the objectives of early treatment when tumour load is small , and selection of the most effective regimen , on the basis of matching type of treatment to the likelihood of drug response ( or resistance ) , are now extended to consideration of treatment for the resistant tumour or tumour in less accessible sites , such as in the brain .
C0518609
treatment
C0006104
brain